A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
About the study
A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Patient is between 21 and 80 years of age
- Patient has an intracranial saccular aneurysm, ruptured or unruptured, suitable for embolization with coils
- Patient is able and willing to comply with protocol and follow-up requirements
EXCLUSION CRITERIA
Exclusion Criteria:
- Pre-planned staged procedure on unruptured aneurysm
- More than one aneurysm requiring treatment during the course of study
- Fusiform aneurysm
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Aneurysms
Age (in years)
21 - 80
Phase
Not Applicable
Participants needed
850
Est. Completion Date
Jun 30, 2026
Treatment type
Interventional
Sponsor
Cerenovus, Part of DePuy Synthes Products, Inc.
ClinicalTrials.gov identifier
NCT03642639
Study number
CNV_2017_01
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?